Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00063297 | Safety and Efficacy of Study Drug Versus Placebo for Negative Symptoms of Schizophrenia | PHASE2 | COMPLETED | 180 | — | — | May 1, 2003 | Oct 1, 2003 | Aug 28, 2009 | 29 | United States |
| Name | Type | Description |
|---|---|---|
| R209130 | DRUG | - |
Inclusion: * Adults aged 18-60 * Current diagnosis of schizophrenia * Significant negative symptoms with few positive symptoms (e.g. hallucinations, delusions) and no evidence of major depression. * Female subjects of childbearing potential must test negative for pregnancy at the time of enrollment...